Completed PHASE4 INTERVENTIONAL 2-arm NCT02534688

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Sponsor: King Chulalongkorn Memorial Hospital

Updated 7 times since 2017 Last updated: Mar 16, 2017 Started: Jun 30, 2015 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Endometriosis and is currently completed. King Chulalongkorn Memorial Hospital leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Apr 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Apr 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Chulalongkorn Memorial Hospital

Data source: King Chulalongkorn Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand